3 November 2016 - Deborah Wilkes
Archived
Worldwide sales at Pfizer Consumer Healthcare increased by 2% on an operational basis to US$798 million in the third quarter of 2016. The 2% operational rise follows sales growth of 7% for Consumer Healthcare during the first half of 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.